Literature DB >> 1563844

Chromosomal deletions and K-ras gene mutations in human endometrial carcinomas.

T Imamura1, T Arima, H Kato, S Miyamoto, T Sasazuki, N Wake.   

Abstract

Forty-two endometrial carcinomas of various stages of progression were analyzed to search for loss of chromosomal regions and for point mutations of ras genes and amplification of Int-2 gene. This approach is particularly favorable for observation of genetic events and their significance in the process of neoplastic conversion by considering the clinico-pathological characteristics of each tumor. At least 3 genetic events, including 18q, 17p deletions, and point mutations at codon 12 of the K-ras gene, are implicated in the development of endometrial carcinomas. Likely targets for allelic losses on chromosomes 18q and 17p are the DCC gene and the p53 gene sequences, respectively. Overall numbers of allelic losses in individual tumors appeared to increase in case of advanced stage tumors, thereby indicating the association of allelic loss accumulation with tumor progression. The genetic features seen in 2 juvenile-type adenocarcinomas and 2 clear-cell carcinomas suggested the possibility that etiological factors providing selective pressure for particular mutation sub-sets during carcinogenesis are probably heterogeneous.

Entities:  

Mesh:

Year:  1992        PMID: 1563844     DOI: 10.1002/ijc.2910510110

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  6 in total

1.  Bcl-2 is closely correlated with favorable prognostic factors and inversely associated with p53 protein accumulation in endometrial carcinomas: immunohistochemical and polymerase chain reaction/loss of heterozygosity findings.

Authors:  M Saegusa; I Okayasu
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

2.  Mutations of the Ki-ras oncogene in carcinoma of the endometrium.

Authors:  R F Caduff; C M Johnston; T S Frank
Journal:  Am J Pathol       Date:  1995-01       Impact factor: 4.307

3.  Suppressed tumorigenicity of human endometrial cancer cells by the restored expression of the DCC gene.

Authors:  H Kato; Y Zhou; K Asanoma; H Kondo; Y Yoshikawa; K Watanabe; T Matsuda; N Wake; J C Barrett
Journal:  Br J Cancer       Date:  2000-01       Impact factor: 7.640

4.  Allelic loss of chromosome 16q in endometrial cancer: correlation with poor prognosis of patients and less differentiated histology.

Authors:  T Kihana; N Yano; S Murao; H Iketani; K Hamada; J Yano; S Murao; H Iketani; K Hamada; J Yano; S Matsuura
Journal:  Jpn J Cancer Res       Date:  1996-11

5.  NIH3T3 cells expressing the deleted in colorectal cancer tumor suppressor gene product stimulate neurite outgrowth in rat PC12 pheochromocytoma cells.

Authors:  W E Pierceall; K R Cho; R H Getzenberg; M A Reale; L Hedrick; B Vogelstein; E R Fearon
Journal:  J Cell Biol       Date:  1994-03       Impact factor: 10.539

6.  Loss of expression and loss of heterozygosity in the DCC gene in neoplasms of the human female reproductive tract.

Authors:  T Enomoto; M Fujita; C Cheng; R Nakashima; M Ozaki; M Inoue; T Nomura
Journal:  Br J Cancer       Date:  1995-03       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.